Central Coast Overdose Prevention
Programs
Substance Use Disorder Support
Providing data collection, analysis, and reporting on: in-field treatment induction for opioid use disorder, patient connections to follow-up services, local overdose mortalities and distribution of overdose-reversing medication.Producing toolkits and publications for community partners wishing to: distribute overdose-reversing medication, educate youth, caregivers, educators, and other community members on substance use, harm reduction, and available resources, and start substance-related conversations between loved ones.Hosting community presentations and a regional Fentanyl and Overdose Prevention Summit on opioids and other substances, medication and treatment, harm reduction, and resources.Coordinating quality improvement reviews and other administrative meetings for a collaborative of EMS and hospital partners that connects patients to treatment and other services.Incentivize people with substance use disorders to begin or stay in recovery and develop habits to be physically healthy.Support families who have a loved one struggling with substance use disorder and honor families who have lost a loved one to substance use disorder and/or fentanyl poisoning by creating a memorial and/or mural.Distributing overdose-reversing medication as well as other harm reduction items (e.g., drug test strips, first aid kits, HIV test kits) through traditional avenues (e.g., drive-throughs, pop-ups, presentations, and community events) as well as non-traditional ones (e.g., stocking medication in defibrillator cabinets, buses and bus shelters, and 24-hour businesses).Creating and maintaining a website portal of resources (e.g., protocol flowcharts for medication-assisted treatment induction, a treatment program directory, infographics on emerging substances) for EMS and hospital partners as well as community membersGeographiesNot indicatedDatesJan 1, 2023 – Dec 31, 2023Source990No causes providedNo populations provided–$1.1K
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)